netFormulary Joint Medicines Formulary NHS
Airedale NHS Foundation Trust
Airedale, Wharfedale and Craven CCG
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Notes:
Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand.  
Chapter Links...
 Details...
08.03.04.01  Expand sub section  Breast cancer
 note 

Adjuvant Endocrine Therapy (extended use) - GP information guide

Anastrozole (Arimidex )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
  • Anastrazole Tablets

     
  • Link  NICE CG164: Familial Breast Cancer (updated March 2017)
       
    Exemestane (Aromasin)
    View adult BNF View SPC online View childrens BNF  Track Changes
    Formulary
    Amber
  • Exemestane Tablets

     
  • Link  NICE TA421: Everolimus with exemestane for treating advanced breast cancer after endocrine therapy (December 2016)
       
    Fulvestrant
    View adult BNF View SPC online View childrens BNF  Track Changes
    Restricted Drug Restricted
    Red
  • Fulvestrant Injection

    Not recommended for use. 
  • Link  NICE TA239: Fulvestrant for the treatment of locally advanced or metastatic breast cancer (December 2011)
    Link  NICE TA503: Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer (January 2018)
       
    Letrozole
    View adult BNF View SPC online View childrens BNF  Track Changes
    Formulary
    Amber
  • Letrozole Tablets

     
  •    
    Tamoxifen
    View adult BNF View SPC online View childrens BNF  Track Changes
    Formulary
    Amber
  • Tamoxifen Tablets
  • Tamoxifen SF Solution

     
  • Link  NICE CG164: Familial Breast Cancer (updated March 2017)
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Green - Drugs suitable for generalised use in accordance with position summary. Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.   

    Amber

    Amber - these drugs require specialist initiation or recommendation  

    Amber SCG

    Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

    Red

    Red - Drugs for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  

    Red ULM

    Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GPs should not be asked to prescribe these products.  

    Grey

    Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.   

    Black

    Black - Drugs not routinely commissioned so should not usually be prescribed  

    netFormulary